Bills › 2025-26
HB 1062: Biomarker testing coverage
Data last updated: bill actions through Aug 23, 2026 · lobbyist reports through Sep 30, 2026 (read Oct 14, 2026)
Providing coverage for biomarker testing.
- Prime sponsor
- Monica Jurado Stonier
- Introduced
- Jan 13, 2025
- Status
- By resolution, reintroduced and retained in present status. (Jan 12, 2026)
- The Legislature's page
- HB 1062 on leg.wa.gov
Floor votes
No floor roll call on file (it didn't pass a chamber, or it was decided without one).
Who lobbied on it 14
| Employer | Lobbyists | To 2026 candidates |
|---|---|---|
| ASTRAZENECA PHARMACEUTICALS LP | 2 | — |
| Fred Hutchinson Cancer Center | 2 | — |
| JOHNSON & JOHNSON SERVICES, INC. | 2 | $3,600 |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK | 1 | — |
| Association of Washington Healthcare Plans | 1 | — |
| BLEEDING DISORDER FOUNDATION OF WA | 1 | — |
| BRISTOL-MYERS SQUIBB CO | 1 | $26,350 |
| ENTERTAINMENT SOFTWARE ASSN(JEAN M LEONARD*) | 1 | — |
| Everytown for Gun Safety Action Fund | 1 | $5,400 |
| GENENTECH(KATHRYN KOLAN) | 1 | — |
| GLAXO SMITHKLINE | 1 | — |
| NATL MULTIPLE SCLEROSIS SOCIETY GREATER NW CHAPTER | 1 | — |
| QUEST DIAGNOSTICS | 1 | — |
| Washington State Medical Oncology Society | 1 | — |
Lobbying reports name a bill number, not a position on it or a version of it. Money: what each employer (as a donor to two or more 2026 candidates) gave to the 2026 campaigns of the members who voted yea or nay on the bill's latest final passage in each chamber.